胃癌分子信号通路与癌性疼痛

国际肿瘤学杂志››2019,Vol. 46››Issue (12): 755-759.doi:10.3760/cma.j.issn.1673-422X.2019.12.010

邢紫阳¹孙春霞²

1 河北中医学院研究生学院，石家庄 050091； 2 河北中医学院附属医院肿瘤二科，石家庄050011

收稿日期:2019-06-24修回日期:2019-07-06出版日期:2019-12-08发布日期:2019-12-09
通讯作者:孙春霞 E-mail:schx1975@163.com
基金资助:
河北省中医药类科研计划（2016164）

Molecular signaling pathways and cancer pain in gastric cancer

Xing Ziyang¹, Sun Chunxia²

1 Graduate School of Hebei College of Chinese Medicine, Shijiazhuang 050091, China; 2 Second Oncology Department of Affilliated Hospital of Hebei College of Chinese Medicine, Shijiazhuang 050011, China

Received:2019-06-24Revised:2019-07-06Online:2019-12-08Published:2019-12-09
Contact:Sun Chunxia E-mail:schx1975@163.com
Supported by:
Scientific Research Project of traditional Chinese Medicine in Hebei Province (2016164)

摘要/Abstract

摘要：丝裂原激活蛋白激酶、磷脂酰肌醇3激酶/蛋白激酶B、AMP活化的蛋白激酶、环氧合酶-2/核转录因子-κB和Wnt/β-catenin等胃癌分子信号通路与癌性疼痛的发生、发展密切相关，了解胃癌分子信号通路在癌性疼痛中的表达和作用，有望为癌性疼痛的治疗提供新思路。

邢紫阳, 孙春霞. 胃癌分子信号通路与癌性疼痛[J]. 国际肿瘤学杂志, 2019, 46(12): 755-759.

Xing Ziyang, Sun Chunxia. Molecular signaling pathways and cancer pain in gastric cancer[J]. Journal of International Oncology, 2019, 46(12): 755-759.

参考文献［31］

［1］	Li ZY, HuYang Y, Yang YT, et al. Moxibustion eases chronic inflammatory visceral pain through regulating MEK, ERK and CREB in rats［J］. World J Gastroenterol, 2017, 23(34): 6220-6230. DOI: 10.3748/wjg.v23.i34.6220.
［2］	Ding CP, Guo YJ, Li HN, et al. Red nucleus interleukin-6 participates in the maintenance of neuropathic pain through JAK/STAT3 and ERK signaling pathways［J］. Exp Neurol, 2018, 300: 212-221. DOI: 10.1016/j.expneurol.2017.11.012.
［3］	王思思, 孙海榉, 杜俊英, 等. 外周神经元PKCε-TRPV1通路在痛转化中的作用及中间信号分子［J］. 中国疼痛医学杂志, 2018, 24(7): 528-532. DOI: 10.3969/j.issn.1006-9852.2018.07.010.
［4］	Sun W, Zhang L, Li R. Overexpression of miR-206 ameliorates chronic constriction injury-induced neuropathic pain in rats via the MEK/ERK pathway by targeting brain-derived neurotrophic factor［J］. Neurosci lett, 2017, 646: 68-74. DOI: 10.1016/j.neulet.2016.12.047.
［5］	Li Q, Liu S, Li L, et al. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway［J］. Glia, 2019, 67(3): 438-451. DOI: 10.1002/glia.23552.
［6］	Guo YJ, Li HN, Ding CP, et al. Red nucleus interleukin-1β evokes tactile allodynia through activation of JAK/STAT3 and JNK signaling pathways［J］. J Neurosci Res, 2018, 96(12): 1847-1861. DOI: 10.1002/jnr.24324.
［7］	Wang C, Kong X, Zhu C, et al. Wu-tou decoction attenuates neuropathic pain via suppressing spinal astrocytic IL-1R1/TRAF6/JNK signaling［J］. Oncotarget, 2017, 8(54): 92864-92879. DOI: 10.18632/oncotarget.21638.
［8］	Oh SH, Yoon MH, Lim KJ, et al. Nefopam downregulates autophagy and c-Jun N-terminal kinase activity in the regulation of neuropathic pain development following spinal nerve ligation［J］. BMC Anesthesiol, 2018, 18(1): 97. DOI: 10.1186/s12871-018-0559-8.
［9］	Meng XW, Gao JL, Zuo JL, et al. Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain［J］. Neurosci Res, 2017, 125: 37-45. DOI: 10.1016/j.neures.2017.06.006.
［10］	Nasseri B, Zaringhalam J, Daniali S, et al. Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways［J］. Int Immunopharmacol, 2019, 70: 225-234. DOI: 10.1016/j.intimp.2019.02.042.
［11］	曲玉娟. TRPV4-MAPK通路在大鼠背根神经节持续受压致神经病理性疼痛中的作用机制研究［D］. 济南: 山东大学, 2016.
［12］	Yang F, Sun W, Luo WJ, et al. SDF1-CXCR4 Signaling contributes to the transition from acute to chronic pain state［J］. Mol Neurobiol, 2017, 54(4): 2763-2775. DOI: 10.1007/s12035-016-9875-5.
［13］	Hu B, Xu G, Zhang X, et al. Paeoniflorin attenuates inflammatory pain by inhibiting microglial activation and Akt/NF-κB signaling in the central nervous system［J］. Cell Physiol Biochem, 2018, 47(2): 842-850. DOI: 10.1159/000490076.
［14］	王婷婷, 冷承浩, 郭昆鹏, 等. 槐果碱通过抑制PI3K/Akt/NFκB信号通路缓解完全弗氏佐剂致大鼠炎性痛作用机制［J］. 中药药理与临床, 2019, 35(1): 63-67. DOI: 10.13412/j.cnki.zyyl.2019.01.014.
［15］	Liu W, Lv Y, Ren F. PI3K/Akt pathway is required for spinal central sensitization in neuropathic pain［J］. Cell Mol Neurobiol, 2018, 38(3): 747-755. DOI: 10.1007/s10571-017-0541-x.
［16］	Jiang SP, Zhang ZD, Kang LM, et al. Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K/Akt2 pathway in the mouse dorsal root ganglion［J］. Exp Neurol, 2016, 275 Pt 1: 11-16. DOI: 10.1016/j.expneurol.2015.11.001.
［17］	Dai WL, Liu XT, Bao YN, et al. Selective blockade of spinal D2DR by levo-corydalmine attenuates morphine tolerance via suppressing PI3K/Akt-MAPK signaling in a MOR-dependent manner［J］. Exp Mol Med, 2018, 50(11): 148. DOI: 10.1038/s12276-018-0175-1.
［18］	Li W, Wong CC, Zhang X, et al. CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis［J］. Oncogene, 2018, 37(50): 6383-6398. DOI: 10.1038/s41388-018-0402-1.
［19］	Yu Y, Hou L, Song H, et al. Akt/AMPK/mTOR pathway was involved in the autophagy induced by vitamin E succinate in human gastric cancer SGC-7901 cells［J］. Mol Cell Biochem, 2017, 424(1-2): 173-183. DOI: 10.1007/s11010-016-2853-4.
［20］	Price TJ, Das V, Dussor G. Adenosine monophosphate-activated protein kinase (AMPK) activators for the prevention, treatment and potential reversal of pathological pain［J］. Curr Drug Targets, 2016, 17(8): 908-920.
［21］	Xiang HC, Lin LX, Hu XF, et al. AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression［J］. J Neuroinflammation, 2019, 16(1): 34. DOI: 10.1186/s12974-019-1411-x.
［22］	Bullón P, AlcocerGómez E, Carrión AM, et al. AMPK phosphorylation modulates pain by activation of NLRP3 inflammasome［J］. Antioxid Redox Signal, 2016, 24(3): 157-170. DOI: 10.1089/ars.2014.6120.
［23］	Maixner DW, Yan X, Gao M, et al. Adenosine monophosphate-activated protein kinase regulates interleukin-1β expression and glial glutamate transporter function in rodents with neuropathic pain［J］. Anesthesiology, 2015, 122(6): 1401-1413. DOI: 10.1097/aln.0000000000000619.
［24］	Qu J, Tao XY, Teng P, et al. Blocking ATP-sensitive potassium channel alleviates morphine tolerance by inhibiting HSP70-TLR4-NLRP3-mediated neuroinflammation［J］. J Neuroinflammation, 2017, 14(1): 228. DOI: 10.1186/s12974-017-0997-0.
［25］	Zhang Y, Tao GJ, Hu L, et al. Lidocaine alleviates morphine tolerance via AMPK-SOCS3-dependent neuroinflammation suppression in the spinal cord［J］. J Neuroinflammation, 2017, 14(1): 211. DOI: 10.1186/s12974-017-0983-6.
［26］	Asiedu MN, Han C, Dib-Hajj SD, et al. The AMPK activator A769662 blocks voltage-gated sodium channels: discovery of a novel pharmacophore with potential utility for analgesic development［J］. PLoS One, 2017, 12(1): e0169882. DOI: 10.1371/journal.pone.0169882.
［27］	Gui Y, Li A, Chen F, et al. Involvement of AMPK/SIRT1 pathway in anti-allodynic effect of troxerutin in CCI-induced neuropathic pain［J］. Eur J Pharmacol, 2015, 769: 234-241. DOI: 10.1016/j.ejphar.2015.11.023.
［28］	Gui Y, Chen L, Duan S, et al. Methyl cinnamate alleviated CCI-induced upregualtion of spinal AMPA receptors and pain hypersensitivity by targeting AMPK［J］. Eur J Pharmacol, 2018, 833: 183-189. DOI: 10.1016/j.ejphar.2018.05.033.
［29］	Lu L, Pan C, Chen L, et al. AMPK activation by peri-sciatic nerve administration of ozone attenuates CCI-induced neuropathic pain in rats［J］. J Mol Cell Biol, 2016, 9(2): 132-143. DOI: 10.1093/jmcb/mjw043.
［30］	Guo L, Yilamu D, Sun L, et al. Association among the expression of β-catenin, cyclin D1 and estrogen receptor-β in human breast cancer［J］. Exp Ther Med, 2015, 10(4): 1423-1428. DOI: 10.3892/etm.2015.2657.
［31］	Zhao Y, Yang Z. Effect of Wnt signaling pathway on pathogenesis and intervention of neuropathic pain［J］. Exp Ther Med, 2015, 16(4): 3082-3088. DOI: 10.3892/etm.2018.6512.

[1]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[2]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[3]	解淑萍, 孙亚红, 汪超.早期肿瘤标志物联合NLR、PLR预测胃癌免疫治疗疗效[J]. 国际肿瘤学杂志, 2024, 51(3): 157-165.
[4]	刘玉兰, 井海燕, 孙静, 宋伟, 沙丹.胃癌免疫治疗疗效预测及预后标志物的研究进展[J]. 国际肿瘤学杂志, 2024, 51(3): 175-180.
[5]	邵慧芳, 王学红, 芦永福.CST1在胃癌进展中的作用机制及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 489-492.
[6]	朱思雨, 王学红, 李文茜, 刘曙.胃癌患者血清FABP1水平及其与幽门螺杆菌感染的关系[J]. 国际肿瘤学杂志, 2023, 50(6): 336-341.
[7]	杨娅, 王慧礼, 刘艳, 郭金凤, 王春霞, 吕敏, 山长平.GCSH基因在胃癌SNU-1细胞增殖和凋亡中的作用研究[J]. 国际肿瘤学杂志, 2023, 50(5): 257-262.
[8]	全祯豪, 徐飞鹏, 黄哲, 黄先进, 陈日红, 孙开裕, 胡旭, 林琳.沉默lncRNA FTX通过miR-22-3p/NLRP3炎症体通路抑制胃癌细胞增殖[J]. 国际肿瘤学杂志, 2023, 50(4): 202-207.
[9]	姬薇, 关泉林, 陈雅蕊, 焦福智, 罗倩文.血脂水平与胃癌的相关性[J]. 国际肿瘤学杂志, 2023, 50(3): 183-185.
[10]	范珊琳, 汪品秀, 孔飞, 周玉洁, 袁文臻.胃癌新辅助化疗后肿瘤退缩分级预测因素的研究进展[J]. 国际肿瘤学杂志, 2023, 50(2): 112-116.
[11]	杨俊, 李荣, 曾建昌.复方苦参注射液联合SOX方案治疗老年晚期胃癌的临床疗效[J]. 国际肿瘤学杂志, 2023, 50(2): 82-86.
[12]	邓莉莉, 段星宇, 李保中.HER2靶向药物及其联合治疗方案在胃及食管胃结合部腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2023, 50(12): 751-757.
[13]	李佳宜, 王跃, 尚兰兰, 徐兴, 赵岩.人工智能技术在胃癌诊断与治疗中的实践与展望[J]. 国际肿瘤学杂志, 2023, 50(11): 677-682.
[14]	于晓鹏, 冯青青, 赵文飞, 赵文文, 魏红梅.靶向治疗联合免疫检查点抑制剂在HER2阳性进展期胃癌中的应用[J]. 国际肿瘤学杂志, 2023, 50(10): 631-635.
[15]	胡茹, 李东霖, 严雪冰.甲基转移酶样蛋白14与肿瘤[J]. 国际肿瘤学杂志, 2022, 49(8): 478-483.

胃癌分子信号通路与癌性疼痛

Molecular signaling pathways and cancer pain in gastric cancer

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献［31］

相关文章15

编辑推荐

Metrics

本文评价